Hepatic steatosis frequently complicates total parenteral nutrition (TPN). Some of the mechanisms responsible were examined in rats receiving calories as dextrose (CHO-TPN) or dextrose plus lipid emulsion (Lipid-TPN). Hepatic triglyceride content increased approximately threefold after CHO-TPN and twofold after Lipid-TPN (P less than 0.02). Hepatic triglyceride fatty acid composition reflected endogenous synthesis. Hepatic acetylCoenzyme A carboxylase specific activity increased fourfold after CHO-TPN and twofold after Lipid-TPN, and it correlated positively with hepatic lipid content (r = 0.82). The activities of the microsomal enzymes of complex lipid synthesis were unchanged in the TPN groups. Both TPN regimens suppressed hepatic triglyceride secretion, measured by the rise in plasma triglyceride and the incorporation of [14C]palmitic acid into plasma triglyceride after intravenous Triton. Hepatic triglyceride secretion correlated negatively with total hepatic lipid content (r = -0.89). CHO-TPN increased the uptake of a radiolabeled triglyceride emulsion and increased hepatic lipase activity, whereas Lipid-TPN decreased both. Both adipose and cardiac lipase were higher for Lipid-TPN animals than for CHO-TPN or control animals. Hepatic 14C-triglyceride content was increased in both TPN groups as compared with controls after the injection of 1-[14C]-palmitic acid. This increment was proportional to the decreased hepatic secretion. 
Introduction
Since the first report that total parenteral nutrition (TPN)' can sustain body composition and promote growth (1) , it has become a routine practice in many medical centers. However, a number of complications have resulted from the use of TPN. One of the most frequent is hepatic dysfunction (2) , especially in infants (3) . Liver dysfunction may be manifested by biochemical disturbances such as hyperammonemia (4) , elevations in serum transaminases and alkaline phosphatase (5), cholestasis (3) , and hepatomegaly, usually as a result of fatty infiltration (6) . In a few cases fibrosis (7) and cirrhosis (8) have occurred.
Two studies (2, 8) indicate that triglyceride infiltration of the liver may occur within a few days of starting TPN in adults and, particularly, in children. Examination of the liver from children who died after various periods on TPN has demonstrated a variety of histological changes including steatosis, cholestasis, bile duct proliferation, portal fibrosis, and, in one patient, cirrhosis (8) . It has not been established that one abnormality inevitably progresses to the next, but steatosis appears to be the earliest and most frequent histological change noted.
The development of an increased hepatic triglyceride content as a consequence of TPN is not well understood. Suggested etiologies include amino acid imbalance (2) , excessive dextrose 1. Abbreviations used in this paper: CoA, coenzyme A; CHO-TPN and Lipid-TPN, total parenteral nutrition regimens that provided all nonprotein energy as a dextrose or provided 33% of the nonprotein calories as a lipid emulsion, respectively; terms also describe animals fed on these regimens; TPN, total parenteral nutrition, total parenteral nutrition-fed. administration (9) , presence of hepatotoxic amino acid metabolites (5), hyperglycemia (10) , excessive lipid infusion (11) , inadequate lipid infusion (12) , and deficiencies of protein (13) , essential fatty acids (14) , or choline (15) . A systematic examination of the pathogenesis of hepatic steatosis has not been reported.
Hepatic steatosis must result from an imbalance in the rate of entry and the rate of removal of fat from the liver. This imbalance may result from alterations in the rates of hepatic: (a) synthesis of fatty acids, as previously reported ( 15) , and triglyceride; (b) secretion of triglyceride or other compounds containing the fatty acyl moiety via plasma or bile; (c) uptake of triglyceride and fatty acids; and/or (d) triglyceride hydrolysis and fatty acid oxidation. Four of these mechanisms were examined in parenterally fed rats that were given two different TPN regimens that reflect the commonly used energy sources in clinical practice. One provided all nonprotein energy as dextrose (CHO-TPN) and the other provided 33% of the nonprotein calories as a lipid emulsion (Lipid-TPN).
Methods TPN technique. Fisher 344 (Charles River Breeding Laboratories, Inc., Wilmington, MA) male rats weighing 180-200 g were used for all experiments. All operative procedures and fluid preparations were carried out under aseptic conditions.
Under intraperitoneal barbiturate anesthesia, the TPN rats were fitted with a superior vena cava catheter as described by Popp and Brennan (16) . Infusions were controlled by Holter roller pumps (model 903; Criticon Inc., Tampa, FL), and the infused volume was increased over 24 h until the required amount of solution was being delivered. One group of animals was catheterized and offered oral chow ad lib. in order to measure the effect of the catheter on weight change and liver lipid. Two other groups were infused with identical volumes of differing concentrations of dextrose to determine the calorie load required for weight gain. After these pilot experiments, animals were randomized into three groups, one offered oral chow ad lib. (Purina Table I Chemical analysis. In all cases total liver lipid content was measured by homogenization of all or part of the organ in a modified Dole's extraction mixture (18) using petroleum ether instead of heptane. Aliquots of the organic phase were dried to a constant weight to allow measurement of the total extractable lipid content of the liver. Plasma lipids were also extracted in modified Dole's mixture. Triglycerides in plasma or liver extracts were measured by an automated fluorimetric technique (19) , and phospholipids were calculated from the lipid phosphorus measured by the method of Ames and Dubin (20) . Radioactivity in plasma or liver extracts was measured by drying aliquots of the extract and redissolving them in a toluene-based scintillation cocktail. All samples were counted in a scintillation counter (LS350; Beckman Instruments Inc., Fullerton, CA) under single or double labeled conditions as appropriate. Quenching was assessed by internal standardization, with the initial addition of appropriate`4C-and then 3H-compounds. Aliquots of liver lipid extract from control and TPN animals were dried under nitrogen, dissolved in a chloroform/methanol (2:1, vol/vol) mixture, and separated by thin-layer chromatography on silica gel-H plates with a solvent system of petroleum ether/diethyl ether/glacial acetic acid, (80:20:1, vol/vol). Triglyceride was identified by exposure to iodine vapor and compared with known standards. The silica gel was extracted again with chloroform/methanol (2:1, vol/vol), and the triglyceride was subsequently hydrolyzed and methylated by sealed tube hydrolysis after the addition of an internal standard of heptadecanoic acid (21) . The fatty acid methyl esters were taken up in isooctane and identified by gas liquid chromatography with a Varian 3700 instrument (Varian Associates, Palo Alto, CA) using a flame ionization detector, nitrogen carrier gas, and a 6-ft glass column packed with 10% SP-2330 100/120 Chromosorb WAW (Supelco; Dell, PA). Peak areas were measured with a CDS III microprocessor (Varian Associates) against the internal standard.
Measurement of the enzymes of fatty acid, triacylglycerol, and phosphatidyl choline synthesis and catabolism. Animals were killed after 7 d of treatment with each nutritional regime and the livers were homogenized in ice-cold medium (0.25 M sucrose, 1 mM EDTA, 10 mM Tris-Cl, pH 7.4) with a motor-driven Teflon-glass homogenizer. The homogenate was centrifuged at 100,000 g for 1 h. Acetyl-Coenzyme (CoA) carboxylase activity in the supernatant was determined by the method of Craig et al. (22) . Microsomal enzyme activities were measured in the total particulate fraction. Protein concentrations were measured by the method of Lowry et al. (23) , with bovine serum albumin as the standard.
Fatty acid CoA ligase activity was measured using 50 ,M
[3H]palmitate and 5 mm ATP as previously described (24) . Glycerol-P acyltransferase activity was assayed using 75 AM palmitoyl CoA and 300 MM [3H]glycerol 3-P (25) . Lysophosphatidic acid acyltransferase activity was determined spectrophotometrically using 55 MM oleoylglycerol-P and 50 AM oleoyl-CoA (26) . Phosphatidic acid phosphatase activity was measured by monitoring orthophosphate release using 1.0 mM phosphatidic acid (27 Three animals from each regime were given intravenous heparin (10 U/100 g) 10 min before they were killed, and aortic blood was collected for measurement of protamine-insensitive lipase activity as previously described (30) , except that a greater volume of plasma (25 Ml) was used. Other groups of animals were killed without heparin injections, and specimens of their adipose tissue, skeletal muscle, and heart were extracted (30) and assayed for lipoprotein lipase by the method of Schotz (31). Aliquots of plasma were assayed with and without pre-incubation with protamine sulfate in order to measure the contribution of hepatic lipase to the total plasma activity.
Hepatic secretion oftriglycerides. 2 h before sacrifice, each animal was given an intravenous injection of 0. Table II ) and Lipid-TPN (regimen 6) with control chow-fed animals (regimen 1). The nutritional composition of these two TPN solutions (Table I) was identical in all respects except for the provision of onethird of the nonprotein calories as a safflower oil emulsion in Lipid-TPN. Rats on both TPN regimens gained weight similarly, although the gain was significantly less than that of controls. (Table III) . The phospholipid content of the extract did not change significantly and was similar to levels previously reported in chloroform/methanol extracts of rat liver after TPN (15) . This suggests that the modified Dole procedure adequately extracted the bulk of phospholipids. The close agreement between the total lipids and the sum of the triglyceride and phospholipid indicates that virtually all of the extracted material was in these two classes.
The fatty acid composition of the liver triglycerides (Table  IV) differed between the TPN rats and controls. Only 0.5% of the triglyceride fatty acid in the CHO-TPN rats were linoleic, as compared with 14.9 and 17.0% in the control and Lipid-TPN rats, respectively. Owing to the larger total amount of (Table V) , revealed few differences between the TPN groups and the oral controls. The activity of phosphatidic acid phosphatase was significantly greater for the Lipid-TPN group than for the control, and that of diacylglycerol acyltransferase was also f Different from oral, P < 0.05. § Different from oral, P < 0.001. 11 Different from oral, P < 0.001, and from CHO-TPN, P < 0.001. ¶ Data from Abbott Laboratories, Hospital Product. The Lipid-TPN groups demonstrated somewhat less activity for diacylglycerol cholinephosphotransferase, possibly as a consequence of the intravenous administration of an appreciable amount of phosphatidylcholine. The major difference in enzyme activity between TPN and control rats was in the regulatory enzyme for fatty acid synthesis, acetyl-CoA carboxylase. This increased fourfold after CHO-TPN and twofold after Lipid-TPN. The specific activity of acetyl-CoA carboxylase in all animals showed a high correlation with the total hepatic content of lipid ( Fig. 1 ) with a correlation coefficient of 0.83 (P < 0.001). Hepatic secretion of triglyceride was estimated from the rise in plasma triglycerides after administration an intravenous dose of Triton WR 1339, and measured more specifically from the incorporation of 1-['4C]palmitate into plasma triglyceride (Table VI) . Both CHO-TPN and Lipid-TPN regimens resulted in a significantly reduced rise in plasma triglycerides as compared with controls, but this was less marked in the CHO-TPN rats. The incorporation of 1-['4C]palmitate into plasma triglyceride was also significantly reduced in both groups, each secreting less than one-half of the amount of labeled triglyceride found in controls. The Triton-induced rise in plasma triglyceride (Fig. 2 A) and the percentage secretion of 1-['4C]palmitate as '4C-triglyceride (Fig. 2 B) triglyceride present in excess of the ratio of the injected emulsion represented hepatic secretion of re-esterified triglyceride fatty acid. Secretion was significantly reduced in both TPN groups (Table VII) as compared with controls. Although the Lipid-TPN group cleared triglyceride from the plasma significantly more slowly than did the other two groups, the recovery of '4C-lipid in the tissue extracts was appreciable (Table VIII) . This group had significantly more '4C-lipid in skeletal muscle than did either of the other groups. Both TPN groups had appreciably more of the injected triglyceride fatty acid recovered in adipose tissue than did the oral control animals. The recovery of the triglyceride '4C-fatty acid in heart tissue was less for both TPN groups than for the oral controls but significantly so only in the CHO-TPN rats. The heart recoveries appeared to correlate better with the radiolabeled CO2 production than did recoveries from any of the other tissues examined, including the liver. Animals given CHO-TPN had significantly more 3H in the liver lipid extracts 20 min after an injection of 2-[3H]glycerol-l-['4C]triolein than did controls (Table VIII) . Lipid-TPN rats had almost 55% less.
When aliquots of the lipid extract were chromatographed, almost all the 3H was in triglyceride. Hepatic '4C-lipid content was similar to that of 3H in the experimental groups. The '4C-derived data are less specific, as they represent the combined effects of uptake, hydrolysis, oxidation, and resecretion of triglycerides, whereas the 3H content is due to uptake of [3H]glycerol triolein and is modified only by subsequent hydrolysis.
The markedly different distribution of the triglyceride fatty acid in the differing dietary states as compared with the similar recoveries of free fatty acid suggested that the lipoprotein lipase activity in these tissues was responsible for the assimilation of triglyceride. The post-heparin plasma lipolytic activities for the control and the two TPN groups were quite different (Table IX) . The control and CHO-TPN groups had relatively similar proportions of post-heparin plasma lipolytic activity, which could be attributed to hepatic and peripheral tissue sources (protamine insensitive and sensitive, respectively) (30).
However, the CHO-TPN group had increased activities of both, particularly protamine insensitive, in comparison with controls. The Lipid-TPN group had a different partition of post-heparin lipolytic activities into hepatic and peripheral tissue activities. Virtually all of the lipolytic activity was inhibited by pre-incubation with protamine sulfate, and the activity that was protamine sensitive was significantly higher than for the orally fed controls. The differences in post-heparin lipolytic activity observed in the three groups were consistent with differences observed in the lipoprotein-lipase activity extracted from the tissues (Table IX) . Lipoprotein lipase activity of adipose tissue was highest in the Lipid-TPN group. Activity in the CHO-TPN rats was lower than in the Lipid-TPN group but was significantly greater than in the oral controls. The extracts of heart tissue demonstrated significantly greater lipolytic activity in the Lipid-TPN group in comparison with either the oral controls or CHO-TPN group, even for this small number of assays. The extracted lipoprotein lipase from heart did not directly parallel the triglyceride fatty acid recovery data from the heart or the '4CO2 generation of the whole animals after intravenous '4C-triglyceride. The variance of the muscle lipase activity of the three animals in each group was larger than for the other tissues and did not yield a significant difference between the groups. The Lipid-TPN group had a muscle activity of 1.19±0.46 nM/mg per m, the oral controls 0.34±0.1 1, and the CHO-TPN 0.25±0.12.
The hepatic content of radiolabeled lipid 1 h after injection of 1-['4C]palmitic acid (Table X) (2) . In addition to the association of steatosis and abnormal function and the possibility of progression to more severe hepatic complications (8) , the accumulation of calories as hepatic triglyceride prevents their use by peripheral tissues. The hypothesis that the increased hepatic triglyceride content in the TPN-fed rats results, in part, from increased fatty acid synthesis is supported by the increase noted in hepatic acetyl-CoA carboxylase activity, the rate limiting step in fatty acid synthesis (36) . The fourfold increase in acetyl-CoA carboxylase activity in CHO-TPN rats is comparable to results from rats fed fat-free, high-carbohydrate chow (37, 38) or given CHO-TPN (I5). Unlike rats given an oral high-fat diet (37, 38) those rats for whom one-third of the dextrose calories were replaced with lipid (Lipid-TPN) did not show depressed acetylCoA carboxylase activity but did show less of a rise in activity than occurred with CHO-TPN. Observed activities of the microsomal enzymes of glycerolipid synthesis in our studies differ from those of reports that show increases in several of the activities after fructose-, glucose-, or fat-enriched diets (39, 40) . The minor changes in enzyme activity we observed in TPN-fed rats are unlikely to play a major role in the development of hepatic steatosis and suggest that their normal level of activity can adequately deal with the increased quantity of newly synthesized fatty acid present under these experimental conditions.
Increased uptake of free fatty acids mobilized from adipose tissue could enhance hepatic triglyceride synthesis; however, this is improbable since the dextrose content of both TPN solutions would induce insulin release and suppress adipose tissue lipolysis. The low percentage of linoleic acid in the CHO-TPN liver triglyceride also supports the concept of endogenous synthesis from dextrose-derived precursors rather than from adipose tissue fatty acids, as the latter contain appreciable amounts of linoleate (41) .
The impaired hepatic triglyceride secretion seen after both TPN regimens showed a high correlation with the total hepatic lipid content and is probably of fundamental importance in the development of steatosis. The difference between the triglyceride mass data and the secretion of '4C-triglyceride may be due to the contribution ofintestinally synthesized triglyceride. As much as 6 mg/h may be secreted into the intestinal lymph of a 300-400-g rat in the fasted state (42 the hepatic steatosis found in Kwashiorkor is due to deficient The mechanism by which TPN suppresses triglyceride hepatic production of this protein (47) , and a similar mechanism secretion is poorly understood. Hepatic toxins and choline may be responsible for reduced triglyceride secretion during deficiency also appear to produce steatosis by suppressing TPN. Apolipoprotein-C has an important regulatory role in triglyceride secretion (43, 44) . CHO-TPN did not include the partitioning of plasma triglyceride between the liver and choline, but Lipid-TPN contained appreciable amounts of peripheral tissues (33) . Qualitative analysis of plasma apoliphosphatidylcholine and both regimens supplied adequate poproteins in rats after CHO-TPN and Lipid-TPN, and after quantities of methionine. In a subsequent study the addition oral chow showed definite differences in apoprotein content of choline to CHO-TPN solution did not reduce steatosis or between the groups, but neither TPN group was deficient in increase the triglyceride secretion (Hall, R. I., unpublished C-apoproteins (Quarfordt, S. H., unpublished observation). In observation). Essential fatty acid deficiency develops rapidly addition to the effect of TPN on plasma triglyceride secretion, and the post-heparin protamine sensitive lipolytic activities were both increased after the Lipid-TPN regimens, indicating that diminished activity of this enzyme could not be responsible for the slower clearance. Recoveries of triglyceride fatty acid in peripheral tissue were also greater than or equal to recoveries in the controls. The decreased hepatic recovery of triglyceride fatty acid, as well as the significantly lower hepatic lipase, was probably the most significant factor in the delayed plasma clearance of triglyceride particles after Lipid-TPN. Even though the triglyceride emulsion was cleared from the plasma more slowly in the Lipid-TPN group, its recovery in a rapidly metabolizing tissue such as the heart was greater than after CHO-TPN. The significantly greater heart lipoprotein lipase activity in the Lipid-TPN than in the CHO-TPN animals may have been responsible for the greater recovery of triglyceride fatty acid in this organ. The 14C02 production from radiolabeled triglyceride closely followed the heart tissue '4C-lipid recovery and suggested that for this interval the heart was an important organ in the burning of this fuel. The enhanced recovery of the triglyceride fatty acid in adipose tissue of both TPN groups also correlated with enhanced adipose lipoprotein lipase activity as compared with that of controls. However, the significantly greater adipose lipase of the Lipid-TPN than of the CHO-TPN was not accompanied by a greater recovery of plasma triglyceride fatty acid in this tissue. The information at hand gives no reasons for this discrepancy. (48) and the known effect of this hormone on lipoprotein lipase (49) . The net effect on plasma triglyceride lipolysis of lipid supplementation to TPN is a shift in plasma triglyceride catabolism to favor peripheral tissues over liver. This is probably one reason for there being less radiolabeled plasma triglyceride recovered in the liver with Lipid-TPN, but the access of plasma triglyceride to the liver is also importantly influenced by its apoprotein content (33) .
The development of hepatic steatosis after both CHO-TPN and Lipid-TPN was most directly related to increased synthesis of fatty acid and impaired hepatic release of triglyceride. The addition of lipid to a TPN regimen has a beneficial effect in terms of distributing the triglyceride fatty acid molecules from the liver to peripheral tissue. Peripheral lipolytic enzymes were activated and the hepatic lipase and the access to the liver were apparently reduced. This effect, along with the enhanced catabolism of fatty acid and the attenuated synthesis of fatty acid in the liver when lipid supplementation was provided, strongly suggests that calories in this form should reduce the hepatic steatotic complications. Biopsy studies in man suggest that hepatic steatosis is reduced when lipid emulsions provide a substantial proportion of the calories in TPN regimens (6, 12) . Animal experiments have indicated that the TPN regimens likely to cause the least steatosis provide -25% of the nonprotein calories as lipid (50) . Our 
